CDKL5 Forum 2017

The 2017 CDKL5 Forum, the flagship meeting on discovery and therapeutic research on CDKL5 deficiency disorder, will be held 29-30 Nov 2017 at the Royal Sonesta Hotel in Cambridge MA, USA. The Forum, the leading scientific conference dedicated solely to therapeutic development for CDKL5 deficiency disorder, is organized by the Loulou Foundation, in collaboration with the Orphan Disease Center at the University of Pennsylvania’s Perelman School of Medicine.

Now in its third year the Forum assembles, by invitation, scientists, clinicians, and drug discovery experts from around the world for presentations, panel discussions, breakout sessions and poster presentations on all topics relating to CDKL5 biology and therapeutic development. For the first time, the Forum is being held in Cambridge, MA, the dynamic epicenter of innovative biotechnology and therapeutic research.

Building on the successes of the last two years, the Forum has already exceeded registration from the previous events and includes representatives from over 60 different academic, non-profit and biotech/pharma institutions from four continents. With recent exciting developments in pre-clinical and clinical research, this year’s Forum promises to highlight the advances made in the community in the past year, and set the agenda for even more progress in the immediate future.

A summary of the proceedings from the 2017 Forum will be made available after the conclusion of the conference and will be accessible on both the Loulou Foundation website (http://www.louloufoundation.org) and the CDKL5 Forum portal (http://www.CDKL5forum.org).